Crescent Pharma Limited, Ramipril 5mg capsules recalled

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 medicines recall for Ramipril 5mg capsules. Crescent Pharma Limited is recalling one batch of Ramipril 5 mg capsules as a precautionary measure due to a potential error at the manufacturing site. Crescent Pharma Limited has received one complaint to date, where it has been identified that a pack of Ramipril 5 mg capsules (Batch Number GR164099) contains blister strips of Amlodipine 5 mg tablets inside the sealed carton.

Pharmacists are advised to stop supplying the affected batches immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process. The alert contains further information relating to identifying patients who have been dispensed the impacted product

Further information, advice and details of the affected batches can be found on the MHRA website.